KELLY GREER: Open Payments
NPI 1073180725 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 75 payments from 15 companies in 2025. Trend: 2023 $1,456 · 2024 $1,515 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $228 |
| Corium, LLC | 8 | $168 |
| Otsuka America Pharmaceutical, Inc. | 12 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Axsome Therapeutics, Inc. | 5 | $77 |
| Janssen Pharmaceuticals, Inc | 4 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Alkermes, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, Azstarys, REXULTI, TRINTELLIX, Auvelity, SPRAVATO, UZEDY.
Industry payments across AL — which companies pay providers there.
